Press Releases | Greenwich LifeSciences, Inc. (GLSI) | GP2

Apr 03, 2025 8:00am EDT

Greenwich LifeSciences Provides Global Update on FLAMINGO-01

Apr 02, 2025 6:00am EDT

Greenwich LifeSciences Announces Positive Immune Response Data from FLAMINGO-01 Phase III Clinical Trial

Mar 27, 2025 6:00am EDT

Greenwich LifeSciences Extends Lock-up of Directors and Officers to March 31, 2026

Mar 17, 2025 6:45am EDT

Greenwich LifeSciences Provides Update on Open Label Safety Data from FLAMINGO-01

Feb 10, 2025 6:00am EST

Greenwich LifeSciences Provides Update on Open Label HLA Data from FLAMINGO-01

Jan 29, 2025 6:00am EST

Greenwich LifeSciences Approved to Add Additional Sites to FLAMINGO-01 in Europe

Jan 27, 2025 6:00am EST

Greenwich LifeSciences Announces Activation of Flamingo-01 in Poland

Jan 23, 2025 6:00am EST

Greenwich LifeSciences Announces Additions of Harvard and Johns Hopkins to Flamingo-01

Jan 22, 2025 6:00am EST

Greenwich LifeSciences Provides Update on Commercial Manufacturing

Jan 14, 2025 6:15am EST

Greenwich LifeSciences Announces Partnership with GBG in Germany for Flamingo-01

1
2
3
4
5
6
7
8
9
Next